NCT03457051

Brief Summary

This study allows patients to take part of the decision making between a unicompartment knee (partial ) or a total Knee replacement . Using the measures of a decision aid questionnaire which explicitly details the risks and benefits of both procedures.The study will use subjective (reported by patient) and objective data (which will be measured) to allow the determination if one option is superior to the other. Information gathered from this study will be used to assist future patients in selecting the surgical option that best fits their life style. A feasibility pilot study of a randomized clinical trial will help to evaluate the outcomes of both procedures and help shape a multicentre Canadian study.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 28, 2014

Completed
3.3 years until next milestone

First Posted

Study publicly available on registry

March 7, 2018

Completed
2.8 years until next milestone

Study Start

First participant enrolled

January 1, 2021

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

July 2, 2021

Status Verified

June 1, 2021

Enrollment Period

4.7 years

First QC Date

November 28, 2014

Last Update Submit

June 30, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index

    The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaire is the sum of WOMAC A (total pain), WOMAC B (stiffness) and WOMAC C (functional impairment) subscores. All the items are scored on a scale of 0-4; lower scores are indicative of lower disease burden. Values are summed for a combined WOMAC score (Total score ranges from 0-96, with higher scores indicating worse pain, stiffness, and functional limitations).

    36 months

Secondary Outcomes (5)

  • Change in Oxford Knee Score (OKS)

    36 months

  • Change in Knee Society Score (KSS)

    36 months

  • Quantitative analysis of gait using EMG and motion capture

    12 months

  • Short Term Recovery

    6 months

  • Clinical Measures

    6months

Study Arms (2)

Total Knee Arthroplasty (TKA)

ACTIVE COMPARATOR

In total (complete) knee arthroplasty (TKA), the orthopaedic surgeon removes the damaged areas of the knee and replaces the components with an artificial joint that is made of plastic or metal.

Procedure: Total Knee Arthroplasty (TKA)

Unicompartmental Knee Arthroplasty (UKA)

EXPERIMENTAL

Unicompartment (partial) knee arthroplasty (UKA) has been available for over 40 years and differs from TKA in that only the most affected and symptomatic compartment (most commonly medial, but occasionally lateral and patella femoral) are replaced

Procedure: Unicompartmental Knee Arthroplasty (UKA)

Interventions

In total (complete) knee arthroplasty (TKA), the orthopaedic surgeon removes the damaged areas of the knee and replaces the components with an artificial joint. The device that will be used is: Stryker TKA Triathlon system implant Cruciate retaining radius femur design. This device has been approved for use by Health Canada.

Total Knee Arthroplasty (TKA)

Unicompartment (partial) knee arthroplasty (UKA) has been available for over 40 years and differs from TKA in that only the most affected and symptomatic compartment (most commonly medial, but occasionally lateral and patella femoral) are replaced. The device that will be used is: Stryker PKR implant cemented and fixed bearing design. This device has been approved for use by Health Canada.

Unicompartmental Knee Arthroplasty (UKA)

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Who report that most of their pain (greater than 75%) is located in the medial part of the knee on a regular basis.
  • With active range of motion from 10° of extension to 100° of flexion.
  • With an intact, competent, anterior cruciate ligament.
  • With overall limb alignment correctable to neutral, indicating a competent medial collateral ligament.
  • With radiographs showing primarily bone-on-bone disease in the medial compartment with minimal wear in both the lateral and patellofemoral compartments of the knee.
  • to 80 years of age.
  • With a Body Mass Index (BMI) less than 40.
  • For the secondary outcome of motion analysis, only patients exhibiting the following characteristics will be suitable for assessment:
  • BMI of 35 or less
  • No other ipsilateral or contralateral lower limb joint disorders

You may not qualify if:

  • Those with inflammatory arthritis
  • Those with no fixed address
  • Those unable to commit to study requirements and follow-ups

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ottawa Hospital

Ottawa, Ontario, K1H 8L6, Canada

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Arthroplasty, Replacement, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • Geoffrey Dervin, MD,MSc,FRCSC

    OHRI / The Ottawa Hospital/ University of Ottawa

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2014

First Posted

March 7, 2018

Study Start

January 1, 2021

Primary Completion

September 1, 2025

Study Completion

September 1, 2025

Last Updated

July 2, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations